What is JOURNAVX? JOURNAVX is a prescription medicine used to treat adults with moderate-to-severe short-term (acute) pain. It is not known if JOURNAVX is safe and effective in children.

Feb 3, 2025 · Journavx (suzetrigine) is a new non-opioid pain-relieving tablet used to treat short-term (acute) moderate to severe pain. Journavx is a sodium channel blocker that relieves pain by blocking …

Jan 30, 2025 · Today, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in …

Feb 3, 2025 · Suzetrigine, marketed under the brand name Journavx, is a novel non-opioid analgesic recently approved by the U.S. Food and Drug Administration (FDA) for the treatment of moderate-to …

Feb 2, 2025 · Find patient medical information for Journavx (suzetrigine) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

Mar 19, 2025 · Journavx (suzetrigine) is a non-opioid pain medication used to treat short-term, moderate-to-severe pain in adults. It works by reducing pain signals before they reach the brain. The …

Jul 10, 2025 · The Food and Drug Administration approved a new non-opioid drug earlier this year called Journavx. It's a pill for severe acute pain that works by blocking plain signals from where someone …

Jan 31, 2025 · The FDA on Thursday approved Vertex Pharmaceuticals' Journavx to treat moderate to severe acute pain in adults. Acute pain is short-term pain often caused by surgery, accident or injury.

Mar 18, 2025 · Journavx (suzetrigine) is a prescription oral tablet for the short-term treatment of moderate to severe pain. Learn about dosage, side effects, and more.

Jan 8, 2025 · JOURNAVX is an oral treatment indicated for moderate-to-severe acute pain in adults. View info on the mechanism of action, efficacy, safety profile, and dosing. See Important Safety …